New targeted treatments for non-small-cell lung cancer – role of nivolumab
Giulia Zago,1,2,* Mirte Muller,1,* Michel van den Heuvel,1 Paul Baas1 1Department of Thoracic Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek (NKI-AvL), Amsterdam, the Netherlands; 2Medical Oncology 2, Istituto Oncologico Veneto (IOV), Padova, Italy *These authors contributed equa...
Saved in:
Main Authors: | Zago G, Muller M, van den Heuvel M, Baas P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/351457bbde574736917aee73bafcbb1c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
by: Huo Geng-wei, et al.
Published: (2021) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
by: Seetharamu N, et al.
Published: (2017) -
Use of nivolumab for colon cancer with Lynch syndrome
by: G. A. Khakimov, et al.
Published: (2020) -
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
by: Denis I. Yudin, et al.
Published: (2021) -
Immunotherapeutic Advances for NSCLC
by: Massafra M, et al.
Published: (2021)